Southeast Asset Advisors Inc. raised its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,934 shares of the medical technology company’s stock after buying an additional 430 shares during the period. Teleflex makes up approximately 0.7% of Southeast Asset Advisors Inc.’s holdings, making the stock its 19th largest position. Southeast Asset Advisors Inc.’s holdings in Teleflex were worth $2,118,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in TFX. Asset Planning Services Ltd. acquired a new stake in shares of Teleflex during the first quarter valued at about $116,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Teleflex during the first quarter valued at $155,000. Mn Services Vermogensbeheer B.V. boosted its stake in Teleflex by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,175 shares of the medical technology company’s stock valued at $213,000 after buying an additional 35 shares during the period. Letko Brosseau & Associates Inc. purchased a new stake in Teleflex during the first quarter valued at $213,000. Finally, Independence Advisors LLC purchased a new stake in Teleflex during the first quarter valued at $215,000. 93.33% of the stock is owned by institutional investors.
Shares of Teleflex Incorporated (TFX) traded up 1.28% during midday trading on Monday, hitting $203.41. 143,397 shares of the stock were exchanged. The firm has a market cap of $9.15 billion, a P/E ratio of 42.22 and a beta of 1.05. The firm has a 50 day moving average of $200.57 and a 200 day moving average of $183.63. Teleflex Incorporated has a 12-month low of $136.53 and a 12-month high of $211.21.
Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 4th. The medical technology company reported $1.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.69 by $0.11. The firm had revenue of $487.90 million during the quarter, compared to analyst estimates of $472.81 million. Teleflex had a net margin of 8.27% and a return on equity of 7.43%. Teleflex’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.52 EPS. Equities analysts forecast that Teleflex Incorporated will post $8.16 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, June 15th. Investors of record on Monday, May 15th were given a $0.34 dividend. The ex-dividend date of this dividend was Thursday, May 11th. This represents a $1.36 dividend on an annualized basis and a yield of 0.67%. Teleflex’s dividend payout ratio is presently 28.22%.
ILLEGAL ACTIVITY WARNING: This news story was reported by BBNS and is the sole property of of BBNS. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://baseballnewssource.com/markets/southeast-asset-advisors-inc-increases-position-in-teleflex-incorporated-tfx/1043889.html.
Several brokerages have recently commented on TFX. Jefferies Group LLC set a $205.00 price objective on shares of Teleflex and gave the stock a “buy” rating in a report on Saturday, March 25th. Deutsche Bank AG increased their target price on shares of Teleflex from $192.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, March 15th. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $217.00 target price on the stock in a report on Tuesday, March 14th. Needham & Company LLC began coverage on shares of Teleflex in a report on Monday, March 6th. They set a “buy” rating and a $221.00 target price on the stock. Finally, Barclays PLC restated a “buy” rating and issued a $205.00 price objective on shares of Teleflex in a report on Wednesday, March 1st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $216.17.
In related news, Director Stuart A. Randle sold 2,500 shares of the stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $205.67, for a total value of $514,175.00. Following the completion of the transaction, the director now owns 7,532 shares in the company, valued at approximately $1,549,106.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stephen K. M.D. Klasko sold 5,200 shares of the stock in a transaction dated Monday, May 15th. The shares were sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the completion of the transaction, the director now owns 12,880 shares of the company’s stock, valued at approximately $2,493,052.80. The disclosure for this sale can be found here. Insiders sold a total of 10,146 shares of company stock valued at $1,996,554 in the last quarter. 2.39% of the stock is currently owned by insiders.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with our FREE daily email newsletter.